The US biotech company Amgen reached an agreement to buy Horizon Therapeutics for more than 25 billion dollars. Horizon holds...
Read moreCurrently, airlines flying in the eurozone must get permits from the EU's so-called "carbon market" to take care of their...
Read moreUntil recently, the shares of Asian technology companies were seen as the most popular among large investors. But the situation...
Read moreU.S. bank analysts expect stocks and bonds to have a good year. However, businesses and consumers will have to deal...
Read moreShares of U.S. technology giants have remained the darling of the New York Stock Exchange for several years. However, this...
Read moreAmazon benefited its products over those of sellers who use the platform to offer similar products and services. France warned...
Read moreThe planet can achieve "no major problems" in eliminating net emissions by 2050, but only if the countries and companies...
Read moreThe aggressive monetary policy applied by the Federal Reserve (Fed) of the United States, the European Central Bank (ECB) and...
Read moreFor a few days, the main stock market indexes experienced a remarkable recovery. But Morgan analysts believe that the upward...
Read moreThe war in Ukraine is generating gigantic expenses for Russia and its finances are no longer what they used to...
Read moreINVESTOR TIMES is an independent publication of economic, finance and investment content, owned and operated by Altas Ventures.
© ATLAS VENTURES SLU, all rights reserved. Any information contained in INVESTOR TIMES is for educational and/or informational purposes only, it is not financial and/or investment advice. INVESTOR TIMES may obtain economic retribution by recommending services or products of third parties. INVESTOR TIMES does not accept, nor will it accept in the future, subsidies or funds from Governments, political parties or public institutions.